Bank of America
QTTB icon

Bank of America’s Q32 Bio QTTB Stock Holding History

Bank of America’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,035
Closed -$3.44K – 6998
2025
Q4 		$3.44K Sell
1,035
-490
-32% -$1.39K ﹤0.01% 6328
2025
Q3 		$3.02K Sell
1,525
-673
-31% -$1.29K ﹤0.01% 7361
2025
Q2 		$3.27K Sell
2,198
-5,094
-70% -$8.68K ﹤0.01% 7359
2025
Q1 		$12K Sell
7,292
-4,636
-39% -$12.5K ﹤0.01% 7085
2024
Q4 		$41K Buy
11,928
+483
+4% +$15.3K ﹤0.01% 6682
2024
Q3 		$511K Sell
11,445
-1,846
-14% -$67.8K ﹤0.01% 5471
2024
Q2 		$239K Buy
13,291
+3,934
+42% +$94.1K ﹤0.01% 5794
2024
Q1 		$159K Sell
9,357
-1,141
-11% -$15.7K ﹤0.01% 6007
2023
Q4 		$115K Sell
10,498
-6,450
-38% -$94.3K ﹤0.01% 6324
2023
Q3 		$357K Sell
16,948
-7,124
-30% -$145K ﹤0.01% 5547
2023
Q2 		$383K Buy
24,072
+539
+2% +$9.68K ﹤0.01% 5446
2023
Q1 		$436K Buy
23,533
+3,443
+17% +$85.8K ﹤0.01% 5459
2022
Q4 		$456K Buy
20,090
+859
+4% +$22.8K ﹤0.01% 5451
2022
Q3 		$557K Buy
19,231
+3,516
+22% +$143K ﹤0.01% 5314
2022
Q2 		$557K Buy
15,715
+10,955
+230% +$374K ﹤0.01% 5362
2022
Q1 		$261K Sell
4,760
-3,221
-40% -$200K ﹤0.01% 6304
2021
Q4 		$523K Sell
7,981
-1,721
-18% -$167K ﹤0.01% 5819
2021
Q3 		$1.37M Buy
9,702
+5,099
+111% +$650K ﹤0.01% 4782
2021
Q2 		$603K Sell
4,603
-624
-12% -$77.9K ﹤0.01% 5278
2021
Q1 		$885K Buy
5,227
+1,744
+50% +$367K ﹤0.01% 4937
2020
Q4 		$708K Sell
3,483
-68
-2% -$13.1K ﹤0.01% 4768
2020
Q3 		$684K Buy
3,551
+1,588
+81% +$356K ﹤0.01% 4487
2020
Q2 		$536K Buy
1,963
+1,006
+105% +$268K ﹤0.01% 4563
2020
Q1 		$268K Sell
957
-8
-0.8% -$2.45K ﹤0.01% 4914
2019
Q4 		$360K Sell
965
-366
-27% -$105K ﹤0.01% 5240
2019
Q3 		$434K Sell
1,331
-1,271
-49% -$432K ﹤0.01% 5185
2019
Q2 		$916K Buy
2,602
+676
+35% +$266K ﹤0.01% 4629
2019
Q1 		$961K Buy
1,926
+235
+14% +$105K ﹤0.01% 4550
2018
Q4 		$681K Buy
1,691
+113
+7% +$42.7K ﹤0.01% 4712
2018
Q3 		$649K Buy
1,578
+616
+64% +$209K ﹤0.01% 4778
2018
Q2 		$353K Sell
962
-427
-31% -$153K ﹤0.01% 5097
2018
Q1 		$468K Buy
+1,389
New +$467K ﹤0.01% 4858

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America's QTTB Position: Q1 2026 in Review

Bank of America sold out of Q32 Bio (QTTB) in Q1 2026, closing a stake of 1,035 shares — an estimated $3.44K sold.

Bank of America first reported a position in QTTB in Q1 2018 and held it in 32 quarters. The position peaked at $1.37M in Q3 2021. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Bank of America reported no remaining Q32 Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,035 Q32 Bio shares in Q1 2026, an estimated $3.44K.
  • Bank of America first reported a position in Q32 Bio in Q1 2018 and held it in 32 quarters.
  • Bank of America's Q32 Bio position peaked at $1.37M in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.